Software-only device estimates total sleep time from an existing pulse oximetry signal, providing additional clinical information without requiring an additional sensor...
The analysis found that women and men with intermediate-risk pulmonary embolism (PE) experienced substantial clot burden reduction, improvements in right-heart function...
FDA authorization enables clinical investigation of a fundamentally different approach for patients with early symptomatic Alzheimer's disease...
CROWN-MV trial will evaluate the safety and effectiveness of the investigational Cephea mitral valve replacement device...
All five patients complete six-month follow-up without predefined prosthesis-related safety events...
ADPKD is the most common inherited kidney disorder, characterized by progressive cyst formation and kidney failure by age 60 in approximately 50 per cent of patients...
Mobile C-arm platform combines imaging assistance and compact design to support operating room workflows...
Clearance is supported by BOLT-DVT findings on clot removal, safety and patient outcomes...
SUBCUT HF II is a multicenter, open-label, randomized controlled investigator-sponsored clinical trial that compared at-home treatment ...
Five-year collaboration framework aims to advance point-of-care diagnostics, clinical performance evaluation, and precision-medicine applications...
